prostate cancer cells
Genome sequencing has taken a step to personalized treatment plans for men with castration resistant prostate cancer. This cancer was once though to be unstoppable since with victims having minimal survival rates. Men only lasted 2 years after therapies began to fail. Recently, however, new therapies have emerged to offer new hope to the afflicted. Exome sequencing and RNA profiling is now being used to identify the perfect drug for an individual to combat that man's personal cancer. This study also holds promise to lead to future treatment options involving brand new test drugs to combat tumors in patients.
This study may seem only important to men, but that isn't so. The technique used to identify the perfect drug to combat prostate cancer tumors could theoretically be used to find a good anti breast cancer drug, or any drug to combat a cancerous tumor. The sequencing and profiling may only be in its early stages, but it shows much potential to become a powerful treatment for cancer or form the base of another new technique.
Further reading on another anti-prostate cancer treatment: http://www.sciencedaily.com/releases/2013/11/131119141951.htm
considering the prevalence of prostate cancer in our population any information gained like this and into how it can be used treat individuals is definitely an asset
ReplyDeleteI think people often overlook the importance of studying things such as genes related to prostate cancer as related to the whole. Instead of simply looking up genes related to breast cancer, it is important as you said for an individual to take into account the similarity of prostate cancer, breast cancer, and other related illnesses to find a cure.
ReplyDelete